The price-cost test in the Art 102 new draft guidelines: when and how to use it
The European Commission has published the long-awaited new draft Guidelines on the application of Article 102. The document provides clarification...
The European Commission has published the long-awaited new draft Guidelines on the application of Article 102. The document provides clarification...
Generative AI promises to reshape the digital world. Agreement is widespread that this technology will have a significant impact on...
The Commission provides initial clarifications on distortion and balancing tests. In a recent staff working paper, the Commission set out...
China’s ambition of a successful innovative pharmaceutical industry needs more fuel China has an ambition to strengthen its innovative pharmaceutical...
Cloud is subject to regulatory scrutiny To achieve the EU’s “Digital Decade” targets, significant investments in cloud infrastructure will be...
The European Union (EU) General Pharmaceutical Legislation (GPL) lays down provisions related to medicinal products authorisation and post-authorisation requirements, preauthorisation...
In light of the European Commission’s recent proposal to revamp the incentive system for orphan medicinal product (OMP) development, we...
EU Telecoms regulation soon to get a revamp The EU may soon see a significant shift in telecoms regulation. Look...
Migraine is a serious condition with large implications for patients. Some patients with severe migraine can receive preventive treatment with...
A key change in the recently published Market Definition Notice is the greater emphasis on non-price elements as relevant parameters...